Opening book details…
About this Medicine article
Sequential treatment with afatinib followed by 3rd generation EGFR-TKI – subgroup analysis of the GIDEON trial: A prospective non-interventional study (NIS) in EGFR mutated NSCLC patients in Germany by Brückl, W; Reck, M; Laack, E; Hermes, B; Rawluk, J; Huber, R M; Hoffmann, C; Schueler, A is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Brückl, W; Reck, M; Laack, E; Hermes, B; Rawluk, J; Huber, R M; Hoffmann, C; Schueler, A
- Publisher
- Oxford University Press; Elsevier BV (ISSN 0923-7534)
- Published
- 2019
- Field
- Medicine (Health Sciences)